
Related news and events
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
Food & Drug Law Institute’s Digital Health Technology and Regulation Conference
Experience
Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics
August 7, 2025
Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.
Related contacts
Related Practices & Industries
Shoulder Innovations Announces $75 Million IPO
July 31, 2025
Cooley advised the underwriters of Shoulder Innovations, a medical technology company exclusively focused on transforming the shoulder surgical care market, in connection with Shoulder Innovations’ $75 million initial public offering (IPO).
Related contacts
Related Practices & Industries
Alumis Announces Merger With ACELYRIN
February 6, 2025
Cooley advised Alumis (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, on its definitive agreement with ACELYRIN to merge in an all-stock transaction.
Related contacts
Related Practices & Industries
H1 Acquires Ribbon Health
January 8, 2025
Cooley advised H1, a global healthcare data technology company, on its acquisition of Ribbon Health.
Related contacts
Related Practices & Industries
Admissions and credentials
Admitted to practice in Florida only. Not admitted to practice in Colorado.
Rankings and accolades
Florida Super Lawyers: Rising Star (2022 – 2023)